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PO-Peracetylated 1-(b-D-glucopyranosyl)-5-phenylbiuret was prepared in the reaction of O-peracetylatedb-D-glucopyranosylisocyanate and phenylurea. The reaction of O-peracetylated N-b-D-glucopyranosylu-
rea with phenylisocyanate furnished the corresponding 1-(b-D-glucopyranosyl)-3,5-diphenyl- as well
as 3-(b-D-glucopyranosyl)-1,5-diphenyl biurets besides 1-(b-D-glucopyranosyl)-3-phenylurea. O-Peracet-
ylated 1-(b-D-glucopyranosyl)-5-(b-D-glycopyranosyl)biurets were obtained in one-pot reactions of
O-peracetylated b-D-glucopyranosylamine with OCNCOCl followed by a second glycopyranosylamine of
b-D-gluco, b-D-galacto and b-D-xylo conﬁgurations. O-Acyl protected 1-(b-D-glucopyranosyl)-3-(b-D-glyco-
pyranosylcarbonyl)ureas were obtained from the reaction of b-D-glucopyranosylisocyanate with C-(gly-
copyranosyl)formamides of b-D-gluco and b-D-galacto conﬁgurations. The O-acyl protecting groups
were removed under acid- or base-catalyzed transesteriﬁcation conditions, except for the N-acylurea
derivatives where the cleavage of the N-acyl groups was faster than deprotection. Some of the new
compounds exhibited moderate inhibition against rabbit muscle glycogen phosphorylase b and human
salivary a-amylase.
 2009 Elsevier Ltd. All rights reserved.C70U
N
C
O
R
R
E
1. Introduction
Carbohydrate processing enzymes (glycoenzymes) catalyze the
assembly and degradation of vital oligo- and polysaccharides.
Discovery of inhibitors of glycoenzymes and revealing their struc-
ture–activity relationship (SAR) is a principal trend in the develop-
ment of carbohydrate-based drugs.1 During our previous research
several inhibitors of glycosidase2–5 and glycogen phosphorylase6,7
(GP) enzymes were synthesized and characterized. The ﬁrst nano-
molar glucose-based inhibitor of rabbit muscle GPb (RMGPb) was
identiﬁed among N-acyl-N0-b-D-glucopyranosyl ureas B (for
selected examples see Table 1, entries 5–7). The strong binding
of the 2-naphthyl derivative (entry 7) was attributed to its
extensive interactions upon binding with the residues lining the
so-called b-pocket of the catalytic channel of the enzyme.8 GP’s
b-pocket is located next to the catalytic site of the enzyme in the
direction of the b-anomeric substituent of bound D-glucose deriva-
tives surrounded by both polar and apolar amino acid side chains.9
In the native RMGPb, this site is occupied by water molecules the
positions of which give insights for the design of new glucose
analogues with substituents that would optimize the network ofll rights reserved.
; fax: +36 52453836.
ák).
N.; et al. Carbohydr. Res. (20interactions with the residues in close vicinity. In order to track
down the nature of interactions in the b-pocket, and the role of
the linker between the sugar and the aromatic part of the molecule
some N-aryl-N0-b-D-glucopyranosyl ureas A (for selected examples
see Table 1, entries 1–3) have been investigated so far. Derivatives
A exhibited weaker binding to RMGPb in comparison to B. To study
the effect of a longer linker of similar composition, synthesis of
biuret derivatives C was envisaged. As the series of compounds B
investigated so far contained mainly apolar residues7 (R = e.g.,
methyl, cyclohexyl, (substituted)phenyl and naphthyl), an effort
to exploit polar interactions in the b-pocket by substituting sugar
rings for R in both B and C was also planned.O
OH
HO
HO
OH H
N
H
N R
O
A
O
OH
HO
HO
OH H
N
H
N
O O
R B 
O
OH
HO
HO
OH H
N
H
N
O O
H
N R C09), doi:10.1016/j.carres.2009.10.016
R
R
E
C
T
80
90
100
110
120
130
140
Table 1
Inhibition of rabbit muscle glycogen phosphorylase b (RMGPb) by selected glucose
derivatives and the new compounds
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a Ki values were calculated for comparison purposes by the Cheng–Prusoff
equation:25 Ki = IC50/(1 + [S]/Km).150
160U
N
CThe synthesis of the protected 1-b-D-glucopyranosyl-5-phenylbiuret 4 was achieved by a reaction of phenylurea with b-D-gluco-
pyranosylisocyanate 310 generated in situ from glucosylamine 211
obtained by catalytic reduction of glucosylazide 112 (Scheme 1).
Compound 4was isolated by crystallization fromMeOH, and depro-
tection was effected by acid-catalyzed transesteriﬁcation to give 5.
We have also attempted to produce 4 in a somewhat shorter
way from b-D-glucosyl urea 613 and PhNCO. In reﬂuxing EtOAc
no reaction occurred between 6 and 1.5 equiv of PhNCO. Using
the same ratio of the reagents in boiling toluene allowed isolation
of 1-b-D-glucosyl-3-phenyl urea 710 in 41% yield. Performing the
reaction in neat, boiling PhNCO gave compound 7 as well as biuret
derivatives 8 and 9 in 4%, 24% and 31% isolated yields, respectively.
This unexpected result could be explained by the presence of water
in the reaction mixture. When 6 was reacted with 1 equiv of
PhNCO in reﬂuxing toluene in the presence of 1 equiv of H2O, the
formation of 7 could be observed. Urea 7 was also formed when
6 and 1 equiv of PhNH2 were reacted in boiling toluene. Finally,Please cite this article in press as: Felföldi, N.; et al. Carbohydr. Res. (20E
D
P
R
O
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heating of 7 in neat PhNCO gave biuret 9. All attempts to avoid
the formation of these products by carefully drying the solvents
and reactants as well as the use of molecular sieves in the reaction
mixtures failed. Structural elucidation of the new biurets 8 and 9
was straightforward by MS and NMR measurements as follows
from the selected characteristic data shown in Scheme 1.
Coupling of a glycosylurea and a glycosylisocyanate could give
1,5-bis-glycosyl biuret derivatives. However, the use of commer-
cial OCNCOCl as a bielectrophilic reagent14,15, and glycosylamines
as nucleophiles offered a simpler and shorter synthetic pathway
towards such target compounds. Thus, reaction of glucopyranosyl-
amine 211 with 0.5 equiv of OCNCOCl gave cleanly the expected
1,5-bis-glucosyl biuret 12 (Scheme 2). Asymmetric derivatives
could also be obtained in two-step, one-pot reactions from 2 by
the addition of 1 equiv of OCNCOCl followed by a second glycosyl-
amine 1016 or 1117,18 to give 14 or 16, respectively. Deacetylation
was performed by the Zemplén protocol to result in high yields
of biurets 13, 15 and 17.
To obtain N-acyl-N0-b-D-glucopyranosyl ureas with a sugar part
in the acyl group the reaction of isocyanate 310 with O-peracetylat-
ed anhydro-aldonamide 1819 was investigated ﬁrst (Scheme 3).
When 3 and 18 were reacted in reﬂuxing EtOAc in equimolar
amounts the conversion of 18 was 25%, and the expected acylurea
20 could be isolated in 32% yield. Raising the temperature to the
boiling point of toluene gave a 56% conversion of 18 and 50% iso-
lated yield for 20. A satisfactory result was achieved by applying
3 in a twofold excess for a full conversion of 18, and the yield of
20 increased to 89%. From a reaction of 3 and O-perbenzoylated
anhydro-aldonamide 1920 (molar ratio 2:1) in boiling toluene 23
was obtained in a 98% yield. In each of the above reactions bis-glu-
copyranosyl urea 21 was also isolated in various amounts which
could be due to the presence of traces of water in the mixtures.21
Attempted deprotection of acyl ureas 20 and 23was successful un-
der neither basic nor acidic transesteriﬁcation conditions because
cleavage of the N-acyl moiety was faster than removal of the O-
acyl-protecting groups. Bis-glucopyranosyl urea 21 was deprotec-
ted under Zemplén conditions to give 2222 in satisfactory yield.
The deprotected compounds were tested for their potency to in-
hibit rabbit muscle glycogen phosphorylase b activity according to
the protocol described earlier,23,24 and the results are summarized
in Table 1. Compounds with two sugar moieties attached to the
terminal nitrogens of either urea 22 (entry 4) or biurets 13, 15
and 17 (entries 9–11) showed very low inhibition of the enzyme
activity. Comparison with the inhibition shown by the phenylbi-
uret derivative 5 (entry 8) this may reveal that the highly polar su-
gar residues opposite to the b-D-glucopyranosyl part of the
compounds are unfavourable for the binding. Among biurets the
b-D-xylopyranosyl derivative 17 proved the most efﬁcient, and this
may be in accord with the less polar character of this residue with
three OH groups compared to four ones in the b-D-gluco- and
galactopyranosyl parts of 13 and 15, respectively. A comparison
of the phenyl substituted derivatives (entries 1, 5 and 8) allows
to conclude that the acyl urea linker is superior to the urea and
the biuret type ones.
Compounds 13 and 22 were also tested against human salivary
a-amylase according to the method reported earlier,3 and exhib-
ited inhibition in the low millimolar range (IC50 10.7 and 8.3 mM,
respectively).
In conclusion, synthesis of 1-(b-D-glucopyranosyl) biurets with
an aromatic and several b-D-glycopyranosyl residues in the 5-posi-
tion allowed to extend structure–activity relationships of glucose
analogue inhibitors of glycogen phosphorylase. Introduction of
the highly polar sugar moieties resulted in weak binding. The
length of the linker composed of NHCO elements between the b-
D-glucopyranosyl and the aromatic parts of the inhibitors proved
to be optimal in the acyl urea series.09), doi:10.1016/j.carres.2009.10.016
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3.1. General methods
Melting points were measured in open capillary tubes or on a
Koﬂer hot-stage and are uncorrected. Optical rotations were deter-Please cite this article in press as: Felföldi, N.; et al. Carbohydr. Res. (20E
D
P
mined with a Perkin–Elmer 241 polarimeter at rt. NMR spectra
were recorded with Bruker 360 (360/90 MHz for 1H/13C) or Bruker
400 (400/100 MHz for 1H/13C) or Avance DRX 500 (500/125 MHz
for 1H/13C) spectrometers. Chemical shifts are referenced to inter-
nal TMS (1H), or to the residual solvent signals (13C). 1H NMR
assignments were established on the basis of gradient enhanced
DQF-COSY spectra.26 Proton chemical shifts and scalar coupling
constants were extracted from the resolution enhanced 1D proton
spectra. COSY spectra were recorded with 512  2 k data points,
spectral widths 4000 Hz, number of transients 4 and recycle delay
of 1.8 s. Microanalyses were performed on a Carlo-Erba analyser
Type 1106. ESIMS were recorded with a Bruker micrOTOF-Q instru-
ment. TLC was performed on DC-Alurolle Kieselgel 60 F254 (Merck),
and the plates were visualized under UV light and by gentle heat-
ing. For column chromatography Kieselgel 60 (Merck, particle size
0.063–0.200 mm) was used. Flasks were ﬂame-dried before per-
forming the reactions. Organic solutions were dried over anhy-
drous MgSO4, and concentrated under diminished pressure at
40–50 C (water bath).
3.2. 1-(2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl)-5-phenyl
biuret (4)
2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosylisocyanate (3) pre-
pared in situ by Ichikawa’s method10 from glucosylamine 211
(0.6 g, 1.73 mmol) was dissolved in toluene (12 mL) and then trea-
ted with phenyl urea (0.47 g, 3.46 mmol). The mixture was re-
ﬂuxed and monitored by TLC (2:1 EtOAc–hexane). When the
reaction was complete, the solvent was evaporated, and the resi-
due was crystallized from MeOH to give 0.37 g (42%) of 4. Mp:
207–209 C; [a]D 23 (c 1.68, acetone); 1H NMR (CDCl3,
360 MHz) d (ppm) 9.42 (s, 1H, NH), 7.44–7.12 (m, 6H, Ar, NH),
5.33 (t, 1H, 3J3,4 = 10.0 Hz, H-3), 5.23 (t, 1H, H-1), 5.10 (t, 1H,
3J4,5 = 9.5 Hz, H-4), 4.98 (t, 1H, 3J2,3 = 9.2 Hz, H-2), 4.33 (dd, 1H,
2J6,60 = 12.6 Hz, H-6), 4.13 (dd, 1H, 3J5,60 = 2.1 Hz, H-60), 3.87 (ddd,
1H, 3J5,6 = 5.0 Hz, H-5), 2.44 (s, 1H, NH), 2.10, 2.08, 2.05 (s, 12H,
4  OCOCH3). 13C NMR (CDCl3, 90 MHz) d (ppm) 170.7, 170.4,
170.0, 169.5 (CO), 155.0, 152.3 (NHCONH), 136.8, 129.4, 129.1,
124.4, 120.5 (Ar), 78.9 (C-1), 73.3, 72.9, 70.0, 68.0 (C-2–C-5), 61.7
(C-6), 20.7, 20.6, 20.56, 20.5 (CH3). ESIMS: [M+Na]+ calcd 532.46,09), doi:10.1016/j.carres.2009.10.016
TR
O
O
F
210
220
230
240
250
260
270
O
OAc
AcO
AcO
OAc
NCO
3
O
OAc
AcO
AcO OAc
CONH2
O
OBzBzO
BzO
OBz
CONH2
O
OAc
AcO
AcO
OAc H
N
O
O
OAc
AcO
AcO
OAc H
N
O
18
19
20 R = Ac (89%)
PhCH3, Δ
PhCH3, Δ
O
OR
RO
RO
OR H
N
H
N
O
21 R = Ac
22 R = H (79%)
+
+
NaOMe, MeOH, rt
ORO
OR
OR
RO
O
BzO
OBz
OBzBzO
H
N
O
H
N
O
O
AcO
OAc
AcOAcO
23 R = Ac, R' = Bz (98%)
Scheme 3.
4 N. Felföldi et al. / Carbohydrate Research xxx (2009) xxx–xxx
CAR 5203 No. of Pages 7, Model 5G
12 November 2009
ARTICLE IN PRESSU
N
C
O
R
R
E
C
found: 532.16. Anal. Calcd for C22H27N3O11 (509.47): C, 51.87; H,
5.22; N, 7.51. Found: C, 51.97; H, 5.24; N, 7.50.
3.3. 1-(b-D-Glucopyranosyl)-5-phenyl biuret (5)
Biuret 4 (250 mg, 0.49 mmol) was dissolved in a mixture of
MeOH and CHCl3 (1:1). A catalytic amount of AcCl was added
and the mixture was stirred at rt. The reaction was monitored by
TLC (1:1 CHCl3–MeOH). When the reaction was complete, it was
neutralized with solid NaHCO3, and then ﬁltered and the solvent
was evaporated. The residue was puriﬁed by column chromatogra-
phy (9:1 CHCl3–MeOH) to give 162 mg (97%) of 5 as a white pow-
der. Mp: 191–193 C; [a]D +4 (c 0.68, MeOH);. 1H NMR (DMSO-
d6 + D2O, 360 MHz) d (ppm) 7.41 (d, 2H, Ar), 7.29 (t, 2H, Ar), 7.04
(t, 1H, Ar), 4.68 (d, 1H, 3J1,2 = 8.9 Hz, H-1), 3.63 (dd, 1H, 3J5,60 =
1.6 Hz, H-60), 3.42 (dd, 1H, 2J6,60 = 12.1 Hz, H-6), 3.19–3.14 (m, 1H,
3J5,6 = 5.8 Hz, H-5), 3.22, 4.26, 4.25 (t, 1H, 3J2,3 = 3J3,4 = 3J4,5 = 8.9 Hz,
H-2,3,4). 13C NMR (DMSO-d6, 90 MHz) d (ppm) 154.6, 152.2
(NHCONH), 138.2, 128.9, 123.1, 119.0 (Ar), 80.3 (C-1), 78.5, 77.3,
72.9, 69.8 (C-2–C-5), 60.8 (C-6). Anal. Calcd for C14H19N3O7
(341.32): C, 49.27; H, 5.61; N, 12.31. Found: C, 49.35; H, 5.66; N,
12.30.
3.4. Reaction of 2,3,4,6-tetra-O-acetyl-b-D-glucopyranosyl
urea13 (6) with phenylisocyanate
Urea 6 (100 mg, 0.26 mmol) was reﬂuxed in neat phenylisocya-
nate(1 mL). The reaction was monitored by TLC (2:1 EtOAc–hex-
ane). When the reaction was complete, the excess amount of
phenylisocyanate was removed by diluting the mixture with hex-
ane. The formed precipitate was ﬁltered, dissolved in CH2Cl2 and
washed with satd aq NaHCO3. The organic layer was separated,
dried and the solvent was evaporated. The residue was separated
by column chromatography (50:1 CH2Cl2–acetone) to give, in the
order of elution, compounds 8, 9 and 710 (4%).
3.4.1. 3-(2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl)-1,5-
diphenyl biuret (8)
Yield: 36 mg (24%), colourless syrup. Rf = 0.89 (25:1 CHCl3–ace-
tone) [a]D +0.2 (c 1.71, DMSO). 1H NMR (CDCl3, 360 MHz) d (ppm)
10.73 (s, 1H, N(CONHC6H5)2), 8.75 (s, 1H, N(CONHC6H5)2), 7.51–
7.09 (m, 10H, Ar), 6.32 (d, 1H, 3J1,2 = 10.0 Hz, H-1), 5.66 (t, 1H,Please cite this article in press as: Felföldi, N.; et al. Carbohydr. Res. (20E
D
P3J3,4 = 9.5 Hz, H-3), 5.39 (t, 1H, 3J4,5 = 9.5 Hz, H-4), 5.16 (t, 1H,
3J2,3 = 10.0 Hz, H-2), 4.52 (dd, 1H, 2J6,60 = 12.6 Hz, H-6), 4.18 (dd,
1H, 3J5,60 = 2.1 Hz, H-60), 4.05 (ddd, 1H, 3J5,6 = 3.7 Hz, H-5), 2.13,
2.06, 2.04, 2.00 (s, 12H, 4OCOCH3). 13C NMR (CDCl3 + DMSO-d6,
90 MHz) d (ppm) 168.6, 167.9, 167.8, 167.7 (CO), 151.8, 151.1
(NCON), 138.3–116.0 (Ar), 79.0 (C-1), 73.1, 71.4, 66.3, 66.1 (C-2–
C-5), 60.1 (C-6), 19.2, 19.1, 19.0, 18.9 (CH3). ESIMS: [M+Na]+ calcd
for C28H31N3O11 (585.57): 608.56, found: 608.19.
3.4.2. 1-(2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl)-3,5-
diphenyl biuret (9)
Yield: 46 mg (31%), white powder. Rf = 0.80 (25:1 CHCl3–ace-
tone). Mp: 226–229 C; [a]D 4 (c 0.64, DMSO). 1H NMR (CDCl3,
360 MHz) d (ppm) 10.24 (s, 1H, NHCON(C6H5)CONHC6H5), 7.56–
7.06 (m, 10H, Ar), 6.44 (t, 1H, 3JH-1,NH = 8.8 Hz, NHCON(C6H5)CON-
HC6H5), 5.28 (t, 1H, 3J3,4 = 9.6 Hz, H-3), 5.11 (t, 1H, 3J1,2 = 9.6 Hz, H-
1), 5.02 (t, 1H, 3J4,5 = 9.6 Hz, H-4), 4.78 (t, 1H, 3J2,3 = 9.6 Hz, H-2),
4.31 (dd, 1H, 2J6,60 = 12.3 Hz, H-6), 4.10 (dd, 1H, 3J5,60 = 1.8 Hz, H-
60), 3.81 (ddd, 1H, 3J5,6 = 4.4 Hz, H-5), 2.09, 2.024, 2.019, 1.98 (s,
12H, 4  OCOCH3). 13C NMR (CDCl3, 90 MHz) d (ppm) 170.6,
170.1, 169.8, 169.4 (CO), 155.8, 152.1 (NCON), 137.4, 135.6,
130.3, 129.9, 129.4, 128.9, 124.1, 120.1 (Ar), 79.8 (C-1), 73.5,
72.5, 69.8, 67.9 (C-2–C-5), 61.5 (C-6), 20.7, 20.5 (CH3). ESIMS:
[M+Na]+ calcd for C28H31N3O11 (585.57): 608.56, found: 608.18.
3.5. 1,5-Bis-(2,3,4,6-tetra-O-acetyl-b-D-glucopyranosyl)biuret (12)
Glucosylamine 211 (400 mg, 1.15 mmol) was dissolved in dry
THF (5 mL), then Et3N (80 lL, 0.58 mmol) and OCNCOCl (46 lL,
0.58 mmol) were added. The mixture was stirred at rt under nitro-
gen atmosphere. After the reaction was complete (TLC, 10:1
EtOAc–hexane) the mixture was diluted with water (5 mL), and
washed with EtOAc (3  5 mL). The organic phase was dried and
the solvent was evaporated under reduced pressure to yield
402 mg (91%) colourless syrup. Rf = 0.83 (10:1 EtOAc–hexane);
[a]D 19 (c 0.97, CHCl3); 1H NMR (DMSO-d6): d (ppm) 9.11 (s,
1H, NH), 8.02 (d, 2H, J = 9.5 Hz, 2  NH), 5.42, 5.34, 4.92, 4.86 (4
pseudo t, 8H, J = 9.5, 9.6 Hz in each, 2  H-1, 2  H-2, 2  H-3,
2  H-4), 4.16–3.94 (m, 6H, 2  H-5, 2  H-6, 2  H-60), 2.00,
1.99, 1.98, 1.95 (4s, 24H, 8  CY3); 13C NMR (CDCl3): d (ppm)
170.6, 170.3, 169.9, 169.4 (COCH3), 154.3 (2  NHCO), 78.7 (C-1),
73.1, 72.8, 70.0, 67.9 (C-2 to C-5), 61.5 (C-6), 20.6, 20.5 (CH3). Anal.09), doi:10.1016/j.carres.2009.10.016
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Calcd for C30H41N3O20 (763.65): C, 47.18; H, 5.41; N, 5.50. Found: C,
47.23; H, 5.50; N, 5.58.
3.6. General procedure I for the synthesis of 1-(2,3,4,6-tetra-O-
acetyl-b-D-glucopyranosyl)-5-(per-O-acetyl-b-D-
glycopyranosyl)biurets 14 and 16
Glucosylamine211 (100 mg, 0.29 mmol)wasdissolved indryTHF
(2 mL), and some freshly heated molecular sieves were added. The
mixture was cooled to 20 C, OCNCOCl (23 lL, 0.29 mmol) was
added, and stirred at 26 C under nitrogen atmosphere for a day.
Then a solution of 2,3,4,6-tetra-O-acetyl-b-D-galactopyranosyl-
amine16 (10, 100 mg, 0.29 mmol) or 2,3,5-tri-O-acetyl-b-D-xylopyr-
anosylamine17,18 (11, 80 mg, 0.29 mmol) in dry THF (2 mL) and Et3N
(40 lL, 0.29 mmol) were added, and the mixture was allowed to
warm up to rt. When the reaction was complete (TLC, 10:1 EtOAc–
hexane) the insoluble materials were ﬁltered off with suction, and
the solventwas removedunder reducedpressure. The crudeproduct
was puriﬁed by column chromatography (7:1 EtOAc–hexane).
3.6.1. 1-(2,3,4,6-Tetra-O-acetyl-b-D-galactopyranosyl)-5-
(2,3,4,6-tetra-O-acetyl-b-D-glucopyranosyl)biuret (14)
Prepared according to General procedure I (Section 3.6) from
glucosylamine 2 (100 mg, 0.29 mmol) and galactosylamine 10
(100 mg, 0.29 mmol). Yield: 183 mg (83%) colourless syrup.
Rf = 0.58 (10:1 EtOAc–hexane); [a]D 15 (c 0.98, CHCl3); 1H NMR
(CD3CN): d (ppm) 7.83 (br s, 1H, NH), 7.60–7.41 (m, 2H, 2  NH),
5.37 (pseudo d, 1H, J = 3.0 Hz, H-4-Gal), 5.34 (pseudo t, J = 9.6 Hz
H-3-Glc), 5.23 (pseudo t, 1H, J = 9.3, 9.4 Hz, H-1-Glc), 5.20–5.15
(m, 2H, H-1-Gal, H-3-Gal), 5.09 (pseudo t, 1H, J = 9.3 Hz, H-2-Gal),
5.07–4.98 (m, 2H, H-2-Glc, H-4-Glc), 4.18 (dd, 1H, J = 4.5, 12.4 Hz,
H-6a-Glc), 4.13–4.09 (m, 1H, H-5-Gal), 4.09–4.00 (m, 3H, H-6a-
Gal, H-6b-Gal, H-6b-Glc), 3.94 (m, 1H, H-5-Glc), 2.21, 2.11, 2.01,
1.99, 1.98, 1.96 (6br s, 24H, 8  CH3); 13C NMR (CDCl3): d (ppm)
170.6, 170.3, 169.9, 169.4 (COCH3), 154.3 (2  NHCO), 79.1, 78.9
(C-1-Glc, C-1-Gal), 73.2, 72.8, 71.9, 71.0, 70.1, 68.0, 67.8, 67.2 (C-2-
Glc to C-5-Glc, C-2-Gal to C-5-Gal), 61.6, 61.0 (C-6-Glc, C-6-Gal),
20.6, 20.5 (CH3). Anal. Calcd for C30H41N3O20 (763.65): C, 47.18; H,
5.41; N, 5.50. Found: C, 47.29; H, 5.54; N, 5.61.
3.6.2. 1-(2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl)-5-(2,3,5-tri-
O-acetyl-b-D-xylopyranosyl)biuret (16)
Prepared according to General procedure I (Section 3.6) from
glucosylamine 2 (100 mg, 0.29 mmol) and xylosylamine 11
(80 mg, 0.29 mmol). Yield: 171 mg (86%) colourless syrup.
Rf = 0.58 (10:1 EtOAc–hexane); [a]D 28 (c 0.58, CHCl3); 1H NMR
(CD3CN): d (ppm) 7.75 (br s, 1H, NH), 7.49 (br s, 2H, 2  NH),
5.35 (pseudo t, 1H, J = 9.4 Hz, H-3-Glc), 5.29 (pseudo t, 1H,
J = 9.1 Hz, H-3-Xyl), 5.23 (pseudo t, 1H, J = 9.4 Hz, H-1-Glc), 5.13
(pseudo t, 1H, J = 9.1 Hz, H-1-Xyl), 5.06–4.88 (m, 4 H, H-4-Glc, H-
2-Glc, H-2-Xyl, H-4-Xyl), 4.17 (dd, J = 4.8, 12.4 Hz, H-6a-Glc), 4.04
(dd, 1H, J = 2.0, 12.4 Hz, H-6b-Glc), 3.98 (dd, J = 5.4, 11.5 Hz, H-
5a-Xyl), 3.93–3.88 (m, 1 H, H-5-Glc), 3.51–3.44 (ddd, 1H,
J = 1.3 Hz, 11.5 Hz, H-5b-Xyl), 2.18, 2.01, 2.00, 1.99, 1.98, 1.96
(5br s, 21 H, 7  CY3); 13C NMR (CDCl3): d (ppm) 170.6, 170.3,
169.9, 169.8, 169.4 (COCH3), 154.4 (2  NHCO), 79.0, 78.7 (C-1-
Glc, C-1-Xyl), 73.1, 72.8, 71.8, 70.0, 69.9, 68.6, 68.0 (C-2-Glc to C-
5-Glc, C-2-Xyl to C-4-Xyl), 63.7, 61.5 (C-6-Glc, C-5-Xyl), 20.5,
20.4 (CH3). Anal. Calcd for C27H37N3O18 (691.59): C, 46.89; H,
5.39; N, 6.08. Found: C, 46.99; H, 5.31; N, 6.15.
3.7. General procedure II for the removal of O-acyl protecting
groups
An O-peracetylated compound (100 mg) was dissolved in dry
MeOH (1 mL), and a solution of NaOMe (1 M in MeOH) was addedPlease cite this article in press as: Felföldi, N.; et al. Carbohydr. Res. (20E
D
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F
to the solution in a catalytic amount. The reaction mixture was
kept at rt. When the reaction was complete (TLC, 7:3 CHCl3–MeOH)
the solution was neutralized with a cation exchange resin Amber-
lyst 15 (H+ form). Filtration and removal of the solvent resulted in
the corresponding deacetylated sugar derivatives.
3.7.1. 1,5-Bis-(b-D-glucopyranosyl)biuret (13)
Prepared according to General procedure II (Section 3.7) from
biuret 12 (100 mg, 0.13 mmol). Yield: 54 mg (96%) colourless syr-
up. Rf = 0.45 (1:3 CHCl3–methanol); [a]D 4 (c 0.51, MeOH); 1H
NMR (D2O): d (ppm) 4.91 (d, 2H, J = 9.3 Hz, 2  H-1), 3.86 (dd,
2H, J = 1.6, 12.3 Hz, 2  H-6a), 3.70 (dd, 2H, J = 5.3, 12.3 Hz,
2  H-6b), 3.52, 3.43, 3.40 (3 pseudo t, 6H, J = 9.0, 9.3 Hz in each
2  H-2, 2  H-3, 2  H-4), 3.51–3.47 (m, 2H, 2  H-5); 13C NMR
(Me2SO-d6): d (ppm) 154.2 (NHCO), 80.3, 78.4, 77.3, 72.8, 69.7
(C-1-C-5), 60.8 (C-6). Anal. Calcd for C14H25N3O12 (427.36): C,
39.35; H, 5.90; N, 9.83. Found: C, 39.46; H, 5.99; N, 9.90.
3.7.2. 1-(b-D-Galactopyranosyl)-5-(b-D-glucopyranosyl)biuret
(15)
Prepared according to General procedure II (Section 3.7) from
biuret 14 (100 mg, 0.13 mmol). Yield: 53 mg (98%) colourless syr-
up. Rf = 0.35 (1:3 CHCl3–MeOH); [a]D 7 (c 0.54, H2O); 1H NMR
(DMSO-d6): d (ppm) 4.65–4.56 (m, 2H), 3.69–3.57 (m, 2H), 3.47–
3.00 (m, 9H), 2.95 (t, 1H); 13C NMR (D2O): d (ppm) 159.6
(2  NHCO), 81.5 (C-1-Glc, C-1-Gal), 77.9, 77.2, 72.6, 70.0 (C-2-
Glc to C-5-Glc, C-2-Gal to C-5-Gal), 61.3 (C-6-Glc, C-6-Gal). Anal.
Calcd for C14H25N3O12 (427.36): C, 39.35; H, 5.90; N, 9.83. Found:
C, 39.44; H, 5.98; N, 9.89.
3.7.3. 1-(b-D-Glucopyranosyl)-5-(b-D-xylopyranosyl)biuret (17)
Prepared according to General procedure II (Section 3.7) from
biuret 16 (100 mg, 0.14 mmol). Yield: 55 mg (96%) colourless syr-
up. Rf = 0.63 (1:3 CHCl3–MeOH); [a]D 12 (c 0.52, H2O); 1H NMR
(D2O): d (ppm) 4.86 (d, 1 H, J = 9.3 Hz), 3.81 (dd, 1H, J = 2.1,
12.6 Hz), 3.65 (dd, 1H, J = 5.1 Hz, 12.6 Hz), 3.51–3.25 (m, 10 H);
13C NMR (D2O): d (ppm) 156.3 (2  NHCO), 81.6, 80.9 (C-1-Glc,
C-1-Xyl), 78.1, 77.1, 72.6, 72.4, 69.9, 69.7 (C-2-Glc to C-5-Glc, C-
2-Xyl to C-4-Xyl), 67.3, 61.2 (C-6-Glc, C-5-Xyl). Anal. Calcd for
C13H23N3O11 (397.34): C, 39.30; H, 5.83; N, 10.58. Found: C,
39.39; H, 5.90; N, 10.65.
3.8. 1-(2,3,4,6-Tetra-O-acetyl-b-D-galactopyranosylcarbonyl)-3-
(2,3,4,6-tetra-O-acetyl-b-D-glucopyranosyl)urea (20)
C-(2,3,4,6-Tetra-O-acetyl-b-D-galactopyranosyl)formamide19 (18,
100 mg, 0.27 mmol) was dissolved in dry toluene (3 mL). Then
some molecular sieves and crystalline isocyanate 310 (202 mg,
0.54 mmol) were added. The reaction was stirred at reﬂux temper-
ature. After one day the reaction mixture was worked up: the
molecular sieves were ﬁltered off with suction and the solution
was concentrated under reduced pressure. The residue was
puriﬁed by column chromatography (100:1 CHCl3–MeOH). Two
products were isolated: 20 (177 mg, 89%) and 2121 (52 mg). Char-
acterization of 20: colourless syrup; Rf = 0.55 (5:1 EtOAc–hexane);
[a]D +18 (c 0.84, CHCl3); 1H NMR (CD3CN): d (ppm) 8.66 (br s, 1H,
NH), 8.64 (d, 1H, J = 9.3 Hz, NH), 5.41 (pseudo d, J = 2.2 Hz, H-4-
Gal), 5.35 (pseudo t, J = 9.6 Hz, H-3-Glc), 5.28 (pseudo t J = 9.3 Hz,
H-1-Glc), 5.22–5.15 (m, 2H, H-2-Gal, H-3-Gal), 5.04, 5.03 (2 pseudo
t, J = 9.3, 9.6 Hz in both, H-4-Glc, H-2-Glc), 4.24–4.02 (m, 6 H, H-6a-
Glc, H-6b-Glc, H-1-Gal, H-5-Gal, H-6a-Gal, H-6b-Gal), 3.91 (ddd,
1H, J = 2.3, 4.8, 9.9 Hz, H-5-Glc), 2.12, 2.03, 2.02, 2.01, 1.99, 1.98,
1.96, 1.93 (8br s, 24H,8  CH3). 13C NMR (CDCl3): d (ppm) 170.6,
170.3, 170.1, 169.9, 169.7, 169.4 (COCH3), 168.0, 152.1 (2  CONH),
78.8, 76.7 (C-1-Glc, C-1-Gal), 74.9, 73.5, 73.0, 70.6, 69.7, 68.2, 67.0,
65.9 (C-2-Glc to C-5-Glac, C-2-Gal to C-5-Gal), 61.7, 61.4 (C-6-Glc,09), doi:10.1016/j.carres.2009.10.016
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C-6-Gal), 20.7, 20.6, 20.5 (CH3). Anal. Calcd for C30H40N2O20
(748.64): C, 48.13; H, 5.39; N, 3.74. Found: C, 48.20; H, 5.43; N,
3.79.
3.9. 1,3-Bis-(b-D-glucopyranosyl)urea (22)
Prepared according to General procedure II (Section 3.7) from
urea 21 (190 mg, 0.26 mmol). Yield 80 mg (79%) amorphous solid.
Lit.27 Mp: 207 C (dec.); Rf = 0.45 (1:3 CHCl3-methanol); [a]D +23 (c
0.59, DMSO), lit.27 [a]D 32.8 (c 2, water); 1H NMR (D2O): d (ppm)
4.86 (d, 1H, J = 9.3 Hz, H-1), 3.86 (dd, J = 1.5, 12.3 Hz, H-6a), 3.69
(dd, 1H, J = 5.2, 12.3 Hz, H-6b), 3.53, 3.38, 3.37 (3 pseudo t, 3H,
J = 9.2, 9.7 Hz in each, H-2, H-3 ,H-4), 3.51–3.48 (m, 1H, H-5). 13C
NMR (D2O): d (ppm) 159.6 (CO), 81.5 (C-1), 77.9, 77.2, 72.6, 70.0
(C-2 to C-5), 61.3 (C-6).
3.10. 1-(2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl)-3-(2,3,4,6-
tetra-O-benzoyl-b-D-glucopyranosylcarbonyl)-urea (23)
C-(2,3,4,6-Tetra-O-benzoyl-b-D-glucopyranosyl)formamide20
(19, 54 mg, 0.086 mmol) was dissolved in dry toluene (1 mL), and
some molecular sieves were added followed by crystalline isocya-
nate 310 (64 mg, 0.172 mmol) mmol). The reaction mixture was
heated to reﬂux temperature. When the reaction was complete
(TLC, 5:1 EtOAc–hexane) the molecular sieves were ﬁltered off
with suction and the residue was concentrated under reduced
pressure. The crude product was puriﬁed by column chromatogra-
phy (1:1 EtOAc–hexane). Two products were isolated: 23 (84 mg,
98%) and 2121 (23 mg). Characterization of 23: colourless syrup;
Rf = 0.53 (1:1 EtOAc–hexane); [a]D 6 (c 0.61, CHCl3); 1H NMR
(CD3CN): d (ppm) 9.01 (br s, 1H, NH), 8.56 (d, 1H, J = 9.2 Hz, NH),
8.05, 7.94, 7.90, 7.78 (4d, 8H, Ar), 7.63–7.32 (m, 12H, Ar), 6.02
(pseudo t, 1H, J = 9.4 Hz, H-3-GlcBz), 5.77 (pseudo t, 1H,
J = 10.1 Hz, H-4-GlcBz), 5.75 (pseudo t, 1H, J = 9.8 Hz, H-2-GlcBz),
5.38 (pseudo t, 1H, J = 9.6 Hz, H-3-GlcAc), 5.34 (pseudo t, 1H,
J = 9.4 Hz, H-1-GlcAc), 5.00, 4.99 (2 pseudo t, 2H, J = 9.4, 9.8 Hz in
both, H-4-GlcAc, H-2-GlcAc), 4.65 (dd, 1H, J = 2.3, 12.3 Hz, H-6a-
GlcBz), 4.57 (dd, 1H, J = 4.6, 12.3 Hz, H-6b-GlcBz), 4.54 (pseudo t,
1H, J = 9.9 Hz, H-1-GlcBz), 4.43–4.39 (m, 1H, H-5-GlcBz), 4.14
(dd, 1H, J = 4.8, 12.3 Hz, H-6a-GlcAc), 4.01 (dd, 1H, J = 1.7,
12.3 Hz, H-6b-GlcAc), 3.94 (ddd, 1H, J = 1.9, 4.4, 9.9 Hz), 2.19,
1.96, 1.94 (3br s, 12H, 4  CH3). 13C NMR (CDCl3): d (ppm) 170.5,
170.0, 169.5, 169.3, 166.0, 165.5, 165.2, 165.1 (COCH3), 168.2,
152.6 (2  CONH), 133.6, 133.3, 133.2, 129.8, 129.7, 129.6, 128.2,
128.3 (CH–Ar), 129.1, 128.7 (C–Ar), 78.4, 76.6 (2  C-1), 76.1,
73.1, 72.8, 69.8, 69.6, 68.8, 68.1(2  C-2 to C-5), 62.8, 61.6 (2  C-U
N
C
O
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6), 20.5, 20.4 (CH3). Anal. Calcd for C50H48N2O20 (996.92): C,
60.24; H, 4.85; N, 2.81. Found: C, 60.19; H, 4.90; N, 2.89.
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